Royal Orch.Hotel (ROHLTD)
CyclicalFairStock Score: 48/100 — MIXED
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹312.35 |
| Market Cap | ₹856.63 Cr |
| P/E Ratio | 26.61 |
| ROCE | 17.36% |
| ROE | 7.38% |
| Dividend Yield | 0.8% |
| Profit Growth | -41.4% |
| Debt/Equity | 2.33 |
| Sales Growth | 36.1% |
| Promoter Holding | 64.06% |
| 52-Week Range | ₹269.4 — ₹562.95 |
| Sector | Leisure Services |
| Book Value | ₹94.23 |
Strengths
- Sales growth of 26.56% shows strong demand momentum.
- ROCE of 17.36% indicates decent operational returns before leverage costs.
- Promoter holding of 64.06% aligns management with minority shareholders.
- Latest quarter still generated ₹10 Cr net profit on ₹113 Cr sales, so the business is not loss-making.
Concerns
- Profit growth is -49.33% despite strong sales growth, showing poor conversion to the bottom line.
- Debt/Equity of 2.64 is very high for a capital-intensive cyclical hotel business.
- ROE of 7.38% is weak for a stock trading at P/B of 3.91.
- Piotroski F-Score of 4/9 suggests deteriorating financial health.
AI Analysis
Let me be honest: Royal Orch Hotels is not the kind of business I would put in my 'wonderful company' box. It is a cyclical hotel operator, and the numbers confirm that. Sales rose 26.56%, which is impressive on the surface, but profit fell 49.33%. That contrast is the first thing that jumps out at me. In the latest quarter, revenue was ₹113 crore and net profit just ₹10 crore — less than a 9% margin. For a leveraged hotel business, that is thin earnings cover. I don't see a durable moat. Hotels are competitive, capital-hungry, and vulnerable to economic cycles. The 64.06% promoter holding is good, and ROCE of 17.36% shows the operations generate something. But ROE of 7.38% tells me that after debt is serviced, shareholders are not getting an exciting return on their equity. Debt/equity of 2.64 is a genuine red flag. With fixed costs and debt, a downturn could squeeze the company badly. The Piotroski score of 4/9 supports my caution — financial health is weak. At ₹348.85, the stock trades at 26.59 times earnings, and those earnings are shrinking. P/B of 3.91 means I am paying nearly four times book value for a business earning 7.38% on that book. The dividend yield of 0.69% is hardly compensation for the risk. The 52-week range reminds me this is a volatile stock; I would not mistake a falling price for a bargain. There is no margin of safety here. This is a cyclical, not a stalwart or fast grower. I would wait on the sidelines until profit growth turns positive, debt declines, and the company proves it can turn higher revenue into higher earnings.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer